|
|
|
40
|
5591A
|
CERUMOL EAR DR (THR/SBI) PROPYLENE GLYCOL | TU
|
PROPYLENE GLYCOL|TURPENTINE OIL
|
CERUMOL
|
11ML
|
A
|
4.35
|
4.35
|
EAR DROP
|
1
|
BOTT
|
THR
|
THORNTON & ROSS LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
5292
|
EENT DRUGS MISCELLANEOPUS
|
2022-04-01
|
2024-03-31
|
|
OTIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5591B
|
WAXONIL 2%|15% EAR DR (SPC) PARADICHLOROBENZENE|TURPENTINE O
|
PARADICHLOROBENZENE|TURPENTINE OIL
|
WAXONIL
|
10ML BOTT
|
A
|
6.4424
|
6.4424
|
BOTT
|
1
|
BOTT
|
SPC
|
SELVOK PHARMACEUTICALS CO
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5236
|
EENT UNCLASSIFIED
|
2024-04-01
|
2026-03-31
|
|
OTIC
|
6
|
EENT UNCLASSIFIED
|
|
|
|
|
42
|
5591B
|
WAXONIL 2%|15% EAR DR (SPC) PARADICHLOROBENZENE|TURPENTINE O
|
PARADICHLOROBENZENE|TURPENTINE OIL
|
WAXONIL
|
10ML
|
A
|
6.80
|
6.80
|
BOTT
|
1
|
BOTT
|
SPC
|
SELVOK PHARMACEUTICALS CO
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5292
|
EENT DRUGS MISCELLANEOPUS
|
2026-04-01
|
|
|
OTIC
|
6
|
EENT DRUGS MISCELLANEOPUS
|
|
|
|
|
42
|
5591C
|
SOLYEAR 8.4% EAR DR (JLP) PARADICHLOROBENZENE
|
PARADICHLOROBENZENE
|
SOLYEAR
|
10ML
|
A
|
5.44
|
5.44
|
BOTT
|
1
|
BOTT
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5292
|
EENT DRUGS MISCELLANEOPUS
|
2026-04-01
|
|
|
OTIC
|
6
|
EENT DRUGS MISCELLANEOPUS
|
|
|
|
|
40
|
5621D
|
DERMOVATE 0.05% CR (GSK/COL) CLOBETASOL
|
CLOBETASOL
|
DERMOVATE
|
30G
|
C
|
23.92
|
23.92
|
CREAM
|
0
|
TUBE
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
5621D
|
DERMOVATE 0.05% CR (GSK) CLOBETASOL (C)
|
CLOBETASOL
|
DERMOVATE
|
30G
|
C
|
26.31
|
26.3134
|
TUBE
|
0
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
42
|
5621D
|
DERMOVATE 0.05% CR (GSK) CLOBETASOL
|
CLOBETASOL
|
DERMOVATE
|
30G
|
C
|
28.95
|
28.95
|
TUBE
|
0
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2026-04-01
|
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
40
|
5621E
|
DERMOVATE 0.05% OINT (GSK/COL) CLOBETASOL
|
CLOBETASOL
|
DERMOVATE
|
30G
|
C
|
23.92
|
23.92
|
OINT
|
0
|
TUBE
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
5621E
|
DERMOVATE 0.05% OINT (GSK) CLOBETASOL (C)
|
CLOBETASOL
|
DERMOVATE
|
30G
|
C
|
26.31
|
26.3134
|
TUBE
|
0
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
42
|
5621E
|
DERMOVATE 0.05% OINT (GSK) CLOBETASOL
|
CLOBETASOL
|
DERMOVATE
|
30G
|
C
|
28.95
|
28.95
|
TUBE
|
0
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2026-04-01
|
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
40
|
5621P
|
CLOBETASOL 0.05% LOT (CHC/ATB)
|
CLOBETASOL
|
CLOBETASOL
|
60ML
|
C
|
6.96
|
6.96
|
LOTION
|
0
|
BOTT
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
40
|
56222
|
CLOBETASOL 0.05% SHAMP (WOC/AHI)
|
CLOBETASOL
|
CLOBETASOL
|
50ML
|
C
|
70.68
|
70.68
|
SHAMPOO
|
0
|
BOTT
|
WOC
|
WOCKHARD LTD INDIA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
56223
|
CLOBETASONE 0.05% SHAMP (GLP) CLOB (C)
|
CLOBETASOL
|
CLOBETASONE
|
100ML
|
C
|
48.93
|
48.93
|
BOTT
|
1
|
BOTT
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
CWS
|
CAPSULE WHOLESALE
|
|
8406
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
ANTI-INFLAMMATORY AGENTS, TOPICAL
|
|
|
|
|
41
|
5641AK
|
ROCEPHIN 1G IV INJ (ROC) CEFTRIAXONE (C)
|
CEFTRIAXONE
|
ROCEPHIN
|
1G VIAL
|
C
|
12.23
|
12.2325
|
VIAL
|
28
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
42
|
5641AK
|
ROCEPHIN 1G IV INJ (ROC) CEFTRIAXONE
|
CEFTRIAXONE
|
ROCEPHIN
|
1G VIAL
|
C
|
12.23
|
12.23
|
VIAL
|
28
|
VIAL
|
ROC
|
ROCHE SERVICIOS S.A.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
40
|
5641BS
|
C ZID 1G INJ (EMC/COL) CEFTAZIDIME
|
CEFTAZIDIME
|
C ZID
|
1G VIAL
|
B
|
4.08
|
4.08
|
INJECTION
|
0
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5641BS
|
C ZID 1G INJ (EMC) CEFTAZIDIME (B)
|
CEFTAZIDIME
|
C ZID
|
1G VIAL
|
B
|
6.8
|
6.7958
|
VIAL
|
28
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
42
|
5641BS
|
C ZID 1G INJ (EMC) CEFTAZIDIME
|
CEFTAZIDIME
|
C ZID
|
1G VIAL
|
B
|
8.70
|
8.70
|
VIAL
|
28
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
40
|
5641BT
|
C TRI 1G IV/IM INJ (EMC/COL) CEFTRIAXONE
|
CEFTRIAXONE
|
C TRI
|
1G VIAL
|
C
|
2.99
|
2.99
|
INJECTION
|
0
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
5641BT
|
C TRI 1G IV/IM INJ (EMC) CEFTRIAXONE (C)
|
CEFTRIAXONE
|
C TRI
|
1G VIAL
|
C
|
4.89
|
4.893
|
VIAL
|
28
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
